Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Blackman DonnaCHIEF FINANCIAL OFFICER | Option exercise | M | — 12.9K sh | Sep 18, 2026 |
| 13 | Aufderhaar DavidChief Financial Officer | Option exercise | M | — 43.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Greig Henry FDirector | Grant or award | A | — 988 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 13 | Hazelbaker JillSee Remarks | Option exercise | M | — 2,547 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Mundy SimonChief Accounting Officer | Tax withholding | F | $227K 4,656 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Frisby Jeffry DDirector | Option exercise | M | $95K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Aufderhaar DavidChief Financial Officer | Tax withholding | F | $184K 62.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Zage George Raymond IIIDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.56M 166.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 12 | Goldthwaite ToddMANAGING DIRECTOR | Tax withholding | F | $95K 1,163 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | O'Connor CaseyChief Legal Officer | Tax withholding | F | $76K 26.0K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Alonso Andres ADirector | Grant or award | A | $130K 3,700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Kramer Andrea AnigatiChief Operating Officer, 10% Owner | Tax withholding | F | $68K 736 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 11 | Nicholas Christopher JamesExecutive Vice President | Open-market sale · 10b5-1 plan | SELL | $160K 1,505 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Kumar MukulPRESIDENT, ENGINEERING | Option exercise · 10b5-1 plan | M | — 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.35M 34.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Sousa Mauad BrunoDirector | Derivative conversion | C | $4.43M 151.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.89M 30.0K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 11 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | Option exercise · 10b5-1 plan | M | — 23.0K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 11 | Nicholas Christopher JamesExecutive Vice President | Open-market sale · 10b5-1 plan | SELL | $149K 1,395 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 10 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | Derivative conversion · 10b5-1 plan | C | $200K 5,252 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 10 | Subaiya Thimaya K.EVP, Operations | Grant or award | A | — 55.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 10 | Cummings MarthaDirector | Open-market sale · 10b5-1 plan | SELL | $11K 713 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Fuchs ThomasDirector | Option exercise | M | — 1,146 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Frisby Jeffry DDirector | Option exercise | M | $36K 1,520 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Budur KumarCHIEF MEDICAL OFFICER | Option exercise | M | $27K 900 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Macdonald AndrewSee Remarks | Option exercise | M | — 2,519 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Leech Christopher T.Director | Grant or award | A | — 914 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Billings Craig ScottDirector, CEO | Grant or award | A | — 8,535 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Wang LingkeDirector, President | Open-market sale · 10b5-1 plan | SELL | $285K 7,431 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Carl Drew ThomasChief Accounting Officer | Grant or award | A | — 2,226 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | O'Hare RobertChief Financial Officer | Grant or award | A | — 46.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Goldthwaite ToddMANAGING DIRECTOR | Option exercise | M | — 1,840 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Fink ChristopherDirector | Grant or award | A | — 1,123 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Ridloff ElenaCFO and CBO | Grant or award | A | — 165.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $202K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Oren IlanDirector | Grant or award | A | — 5,054 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Adkins KatherineChief Legal Officer | Grant or award | A | — 30.2K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Ridloff ElenaCFO and CBO | Disposition to issuer | D | — 165.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Fullalove Craig JeffreyCFO | Grant or award | A | — 1,691 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | McKee CharlotteCMO and Head of R&D | Disposition to issuer | D | — 155.7K sh | Sep 18, 2026 traded Sep 17, 2026 |